Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REALITY Study: Analysis of a Prospective REgistry to Assess Outcome and Toxicity of Targeted RadionucLide TherapY in Patients With mCRPC in Clinical Routine.

NCT04833517 is registered in ClinicalTrials.gov with Universität des Saarlandes as lead sponsor.

NCT NCT04833517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04833517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REALITY Study: Analysis of a Prospective REgistry to Assess Outcome and Toxicity of Targeted RadionucLide TherapY in Patients With mCRPC in Clinical Routine.
Lead sponsor
Universität des Saarlandes
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2016
Completion date
December 31, 2025
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced prostate carcinoma, castration resistant prostatic cancer, prostate cancer metastatic